Patents by Inventor Mark Alan Massa

Mark Alan Massa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8097733
    Abstract: The invention relates to compounds of formula (I) processes for their preparation, their use as 5-lipoxygenase inhibitors and pharmaceutical compositions containing the same.
    Type: Grant
    Filed: November 24, 2008
    Date of Patent: January 17, 2012
    Assignee: Pfizer Inc.
    Inventors: Edgardo Alvira, Matthew J. Graneto, Margaret Lanahan Grapperhaus, Kaliappan Iyanar, Todd Michael Maddux, Matthew William Mahoney, Mark Alan Massa, Kirby Ray Sample, Michelle Ann Schmidt, Ronald Edward Seidel, Jon Gordon Selbo, Michael Brent Tollefson, Richard Alan Vonder Embse, Grace Mary Wagner, Scott Santford Woodard
  • Patent number: 6017918
    Abstract: The present invention provides compounds having the Formula I ##STR1## The present invention also provides methods of treating atherosclerosis, coronary heart disease, and restenosis using the compounds of Formula I, and pharmaceutical compositions comprising the compounds of Formula I.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: January 25, 2000
    Assignee: Warner-Lambert Company
    Inventors: Helen Tsenwhei Lee, Mark Alan Massa, William Chester Patt, Bruce David Roth
  • Patent number: 5891892
    Abstract: Novel small molecular biaryl compounds as inhibitors of endothelin converting enzyme are described, as well as methods for the preparation and pharmaceutical compositions of the same, which are useful in treating elevated levels of endothelin, acute and chronic renal failure, hypertension, myocardial infarction, myocardial ischemia, cerebral vasospasm, cerebral ischemia, cerebral infarction, cirrhosis, septic shock, congestive heart failure, endotoxic shock, subarachnoid hemorrhage, arrhythmias, asthma, preeclampsia, atherosclerotic disorders including Raynaud's disease and restenosis, angina, cancer, pulmonary hypertension, ischemic disease, gastric mucosal damage, hemorrhagic shock, ischemic bowel disease, stroke, benign prosthatic hyperplasia (BPH), and diabetes.
    Type: Grant
    Filed: October 14, 1997
    Date of Patent: April 6, 1999
    Assignee: Warner-Lambert Company
    Inventors: Xue-Min Cheng, Mark Alan Massa, William Chester Patt